Ground News

News from Cardiac Interventions Today

See all of Cardiac Interventions Today news coverage in one place. Discover how Cardiac Interventions Today’s media bias informs their coverage and compare with thousands of other news outlets.

In total, 30 have been published by Cardiac Interventions Today which Ground News has aggregated in the past 3 months.

The Ground News media bias check for Cardiac Interventions Today is unknown. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides.

Cardiac Interventions Today’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Cardiac Interventions Today

Where is Cardiac Interventions Today located?Cardiac Interventions Today's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Cardiac Interventions Today News

Health Canada · Toronto

Evoque tricuspid valve replacement system gains Health Canada approval - Cardiovascular News

Edwards Lifesciences Evoque transcatheter tricuspid valve replacement system. Edwards Lifesciences has announced that the company’s Evoque tricuspid valve replacement system has received Health Canada’s approval for the treatment of tricuspid regurgitation (TR). The Evoque system is indicated for the improvement of health status in patients with symptomatic severe TR despite optimal medical therapy (OMT), for whom tricuspid valve replacement is …See the Story

Medtronic’s GSR-DEFINE Study of Symplicity Spyral RDN System Enrolls First United States Patient - Cardiac Interventions Today

June 11, 2025—Medtronic announced the treatment of the first patient in the United States in the Global SYMPLICITY Registry (GSR) DEFINE. The clinical study is documenting the safety and effectiveness of the company’s Symplicity Spyral renal denervation (RDN) system in a real-world setting. The company stated that the first United States procedure was performed by Stan Thornton, MD, of Thomas Hospital, an affiliate of Infirmary Health in Fairhop…Maryland · Maryland See the Story

Jenscare’s Lux-Valve Plus TTVR System Evaluated in TRINITY Study - Cardiac Interventions Today

June 9, 2025—Jenscare Scientific Co., Ltd. recently announced that 30-day follow-up results from the TRINITY trial of the company’s Lux-Valve Plus transcatheter tricuspid valve replacement (TTVR) system were presented by Professor Thomas Modine, MD, at EuroPCR 2025. According to the company, TRINITY is a global prospective, multicenter, single-arm clinical trial evaluating the safety and efficacy of Lux-Valve Plus in patients with severe tricusp…Maryland · Maryland Read Article

Elixir Medical’s DynamX Studied at 3 Years in BIOADAPTOR RCT - Cardiac Interventions Today

May 30, 2025—Elixir Medical recently announced 3-year results from the BIOADAPTOR randomized controlled trial (RCT) comparing the company’s DynamX coronary sirolimus-eluting bioadaptor system to the standard-of-care Resolute Onyx zotarolimus drug-eluting stent (DES; Medtronic). The study was composed of 445 patients enrolled at 34 centers in Japan, Europe, and New Zealand. According to the company, the results demonstrated sustained low adverse …Maryland · Maryland Read Article

Meril’s Myval Devices for TAVR Evaluated at 1 Year in LANDMARK RCT - Cardiac Interventions Today

May 29, 2025—Meril Life Sciences recently announced 1-year results from its LANDMARK pivotal trial of its series of Myval transcatheter heart valves (THVs) for transcatheter aortic valve replacement (TAVR). The company stated that the randomized, noninferiority trial is comparing the company’s series of balloon-expandable Myval THVs with contemporary TAVR device series—balloon-expandable Sapien TAVR systems (Edwards Lifesciences) and self-expand…Paris, France · Paris Read Article

Boston Scientific ends TAVR sales; J&J shares Monarch robot data

100% Center coverage: 1 sources

Boston Scientific said it would halt worldwide sales of its Acurate devices due to “increased clinical and regulatory requirements.”Johnson & Johnson · Boston See the Story

Boston Scientific’s Early ACURATE PRIME Registry Data Presented - Cardiac Interventions Today

May 27, 2025—Boston Scientific recently announced data from the Early ACURATE PRIME Registry, which is evaluating the Acurate Prime aortic valve system. Boston Scientific noted that the findings are the first large, real-world clinical data on the company’s latest transcatheter aortic valve replacement (TAVR) device after its approval and launch in Europe last year. On August 27, 2024, the company announced CE Mark approval of the self-expanding…Sweden · Sweden Read Article

TriCares Topaz TTVR System Evaluated in TRICURE FIH Study - Cardiac Interventions Today

May 27, 2025—TriCares SAS recently announced the presentation of data from the TRICURE first-in-human (FIH) trial of its investigational Topaz transcatheter tricuspid valve replacement (TTVR) system. The 30-day postprocedural data were from 20 tricuspid regurgitation (TR) patients treated with the Topaz device at eight specialist cardiac centers in Europe. The findings were presented by Julien Dreyfus, MD, in a late-breaking session at the EuroP…Maryland · Maryland Read Article

Abbott Receives FDA Approval for Tendyne™, First-of-Its-Kind Device to Replace the Mitral Valve Without Open-Heart Surgery

60% Center coverage: 5 sources

The Tendyne system replaces mitral valves that are not functioning properly due to a buildup of calcium in the base of the valves, known as severe mitral annular calcification (MAC)Tendyne offers a new treatment option for patients who are not…Fentanyl · United States See the Story

News from Cardiac Interventions Today

News from Cardiac Interventions Today

Information about Cardiac Interventions Today

Media Bias Ratings

Factuality

Ownership

Top Cardiac Interventions Today News

Evoque tricuspid valve replacement system gains Health Canada approval - Cardiovascular News

Medtronic’s GSR-DEFINE Study of Symplicity Spyral RDN System Enrolls First United States Patient - Cardiac Interventions Today

Jenscare’s Lux-Valve Plus TTVR System Evaluated in TRINITY Study - Cardiac Interventions Today

Elixir Medical’s DynamX Studied at 3 Years in BIOADAPTOR RCT - Cardiac Interventions Today

Meril’s Myval Devices for TAVR Evaluated at 1 Year in LANDMARK RCT - Cardiac Interventions Today

Boston Scientific ends TAVR sales; J&J shares Monarch robot data

Boston Scientific’s Early ACURATE PRIME Registry Data Presented - Cardiac Interventions Today

TriCares Topaz TTVR System Evaluated in TRICURE FIH Study - Cardiac Interventions Today

Abbott Receives FDA Approval for Tendyne™, First-of-Its-Kind Device to Replace the Mitral Valve Without Open-Heart Surgery

Similar News Topics

Topics Most Covered by Cardiac Interventions Today

Sources Covering Similar Topics

Breaking News Topics Related to Cardiac Interventions Today